Flutamide: Clinical Trials

5 trials of Flutamide, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting, 1 terminated, 1 unknown. 5 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 45Completed 2, Recruiting 1, Terminated 1, Unknown 1

Follow Flutamide: new trials by email Literature Review of Flutamide trials Research Report on Flutamide

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Autonomic and Renal Contributions to Hypertension With ADT
Gonadotropin Releasing Hormone Agonists (GNRH), Androgen receptor (AR) inhibitor, Placebo - Androgen Deprivation Therapy, Prostate Cancer
Phase 4RecruitingVirginia Commonwealth University602026-08-012026-11-02
Contributions to Hypertension With Androgen Deprivation Therapy
Gonadotropin Releasing Hormone Agonists (GNRH), Androgen receptor (AR) inhibitor, Placebo - Androgen Deprivation Therapy, Prostate Cancer
Phase 4TerminatedUniversity of Colorado, Denver102023-09-202026-09-02
Androgen Deprivation Therapy on Bone Mineral Density Change in Prostate Cancer Patients
Leuprorelin, Goserelin, Triptorelin - Prostatic Neoplasms
Phase 4UnknownWonju Severance Christian Hospital1642020-01-232021-07-29
Study on Enzalutamide and Flutamide in Patients With Castration Resistant Prostate Cancer
Enzalutamide, Flutamide, Androgen deprivation therapy - Prostate Cancer
Phase 4CompletedAstellas Pharma Inc2062016-11-022024-12-09
Effectiveness of Flutamide in Treating Women With Premenstrual Dysphoric Disorder
Flutamide, Placebo - Premenstrual Syndrome
Phase 4CompletedWeill Medical College of Cornell University1152005-02-012020-01-07

Conditions studied

Prostatic Neoplasms (4)  ·  Hypertension (2)  ·  Kidney Diseases (2)  ·  Primary Dysautonomias (2)  ·  Premenstrual Dysphoric Disorder (1)  ·  Premenstrual Syndrome (1)

Sponsors

Astellas Pharma Inc (1)  ·  University of Colorado, Denver (1)  ·  Virginia Commonwealth University (1)  ·  Weill Medical College of Cornell University (1)  ·  Wonju Severance Christian Hospital (1)

Countries

United States (2)  ·  Japan (1)  ·  South Korea (1)

Top investigators

Matthew Babcock, PhD (2)  ·  Jinsung Park, MD. PhD. (1)  ·  Margaret Altemus, MD (1)

NIH funding

K01HL164978 (1), R34MH072878 (1)